http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2285263-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1998-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3f29cd5f4cc4bb95e0ec55046e952f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a188b7ce2ab3f76111fc971de979811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6bb74d4a553b5293aea4a1ce408eeb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9c4760c70c7901dc1138011092e4ff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8213ddfae94165e67f16c4e1ff5de2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5f537fef48ed16e89585af4dca94bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09e635100bdd911939cfeaac60bafa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b656d48ac7403e782b9cd44cb4a7d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a6374c4fb692769145cc6386000acb
publicationDate 1998-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2285263-A1
titleOfInvention Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
abstract Novel heterocyclic ether compounds having formula (I) wherein A, m, R, X, Y1, Y2 and Y3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.
priorityDate 1997-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414138285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414372168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260

Total number of triples: 37.